Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s): N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Healthcare

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).

NDAQ:MNMD - Post by User

Mind Medicine (MindMed) Inc

Bullboard Posts

Comment by josameyeron Dec 07, 2011 6:48pm

296 Views

Post# 19301408

RE: Stanley,turning point for Brigus.

Will the release of the NI 43-101 next week provide a turning point for Brigus Gold ? It very well could, if the numbers are substantive. It baffles me, to see Brigus Gold stuck at its current price range, with where the current price of gold is at. Perhaps some tax loss selling.And a persistant strange trading format by some entities.The Broadway loan between Calais resources and Brigus Gold expired on December1. Rumour has it thusfar 1.2 million hasbeen paid, and negotiations are ongoing for a settlement. 5 drills still turning which includes one drilling at the Gibson site.Hoping for a breakout in the very near future. As always DYODD. Cheers to all Josa.

Bullboard Posts

Level up your trading with BMO InvestorLine’s enhanced features